Franklin Resources’s CASI Pharmaceuticals CASI Stock Holding History

Franklin Resources’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-19,743	Closed	-$144K	–	2887
2023 Q4	$144K	Sell	19,743 -34	-0.2%	-$164	﹤0.01%	2419
2023 Q3	$50.6K	Sell	19,777 -5,146	-21%	-$12.2K	﹤0.01%	2535
2023 Q2	$62.1K	Hold	24,923	–	–	﹤0.01%	2595
2023 Q1	$57.3K	Buy	24,923 +377	+2%	+$726	﹤0.01%	2175
2022 Q4	$43K	Hold	24,546	–	–	﹤0.01%	2231
2022 Q3	$64K	Buy	24,546 +243	+1%	+$782	﹤0.01%	2172
2022 Q2	$70K	Sell	24,303 -11,787	-33%	-$51.2K	﹤0.01%	2200
2022 Q1	$292K	Hold	36,090	–	–	﹤0.01%	2022
2021 Q4	$289K	Buy	+36,090	New	+$359K	﹤0.01%	2096

Other funds holding CASI

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

HCM

Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CFM

Catalyst Funds Management Sydney NSW, Australia $1.78B AUM 107.3% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources's CASI Position: Q1 2024 in Review

Franklin Resources sold out of CASI Pharmaceuticals (CASI) in Q1 2024, closing a stake of 19,743 shares — an estimated $144K sold.

Franklin Resources first reported a position in CASI in Q4 2021 and held it in 9 quarters. The position peaked at $292K in Q1 2022. 20 funds tracked by Wall St. Rank hold CASI as of Q1 2024.

Franklin Resources reported no remaining CASI Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Franklin Resources sold 19,743 CASI Pharmaceuticals shares in Q1 2024, an estimated $144K.
Franklin Resources first reported a position in CASI Pharmaceuticals in Q4 2021 and held it in 9 quarters.
Franklin Resources's CASI Pharmaceuticals position peaked at $292K in Q1 2022.
20 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q1 2024.

Based on Franklin Resources's 13F filing for Q1 2024, filed 13 May 2024.